This report outlines the rationale and evidence for the new polio eradication strategy, including switching to bivalent OPV and introducing inactivated poliovirus vaccine.
Answers are grounded in this paper and cite their sources.
Supports updated polio eradication planning; leaves open prospective validation of bivalent OPV-IPV implementation.
Polio eradication requires the removal of all polioviruses from human populations, whether wild poliovirus or those emanating from the oral poliovirus vaccine (OPV). The Polio Eradication & Endgame Strategic Plan 2013-2018 provides a framework for interruption of wild poliovirus transmission in remaining endemic foci and lays out a plan for the new polio end game, which includes the withdrawal of Sabin strains, starting with type 2, and the introduction of inactivated poliovirus vaccine, for risk mitigation purposes. This report summarizes the rationale and evidence that supports the policy decision to switch from trivalent OPV to bivalent OPV and to introduce 1 dose of inactivated poliovirus vaccine into routine immunization schedules, and it describes the proposed implementation of this policy in countries using trivalent OPV.
No takes yet. Share an insight, caveat, or question.
Sutter et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: